Table 2 Patient and disease characteristics

From: Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

 

N (40)

%

Age (in years) (range)

41 (20–72)

 

Sex

 Female

28

70

 Male

12

30

PS (available for 37 patients)

 0

27

73

 1

9

24

 2

1

3

Tumour location (multifocal in four cases)

 Extraabdominal

28

70

 Abdominal wall

7

18

 Intraabdominal

8

20

Previous treatment before enrolment

Surgery

34

85

Radiotherapy (median dose 50 Gy)

9

23

Hormonal therapy

18

45

Treatment with NSAID

12

30

Chemotherapy

8

20

  1. Abbreviations: NSAID=non-steroidal anti-inflammatory drug; PS=performance status.